Comparison of the potency of newly developed and currently available oximes to reactivate nerve agent-inhibited acetylcholinesterase in vitro and in vivo

被引：12
|
作者：
Kuca, K [1 ]
Bartosova, L [1 ]
Kassa, J [1 ]
Cabal, J [1 ]
Bajgar, J [1 ]
Kunesova, G [1 ]
Jun, D [1 ]
机构：
[1] Fac Mil Hlth Sci, Dept Toxicol, Hradec Kralove, Czech Republic
来源：
CHEMICO-BIOLOGICAL INTERACTIONS | 2005年 / 157卷
关键词：
acetylcholinesterase; reactivator; oxime; tabun; cyclosarin;
D O I：
10.1016/j.cbi.2005.10.054
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
09
引用
收藏
页码：367 / +
页数：2
相关论文
共 35 条
  • [21] A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats
    Kassa, Jiri
    Karasova, Jana
    [J]. DRUG AND CHEMICAL TOXICOLOGY, 2007, 30 (02) : 117 - 131
  • [22] Design, synthesis and in vitro evaluation of a promising new class of bifunctional uncharged hybrid reactivators for nerve agent-inhibited human acetylcholinesterase
    Dias, Jose
    De Sousa, Julien
    Gastellier, Anne-Julie
    Rousseau, Catherine
    Courageux, Charlotte
    Timperley, Christopher
    Brown, Richard
    Santoni, Gianluca
    Weik, Martin
    Baati, Rachid
    Nachon, Florian
    [J]. JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 210 - 211
  • [23] A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice
    Kassa, Jiri
    Humlicek, Vojtech
    [J]. DRUG AND CHEMICAL TOXICOLOGY, 2008, 31 (01) : 127 - 135
  • [24] A comparison of the efficacy of a bispyridinium oxime -: 1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods
    Kuca, K
    Cabal, J
    Kassa, J
    [J]. PHARMAZIE, 2004, 59 (10): : 795 - 798
  • [25] Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics
    Worek, Franz
    Koller, Marianne
    Thiermann, Horst
    Wille, Timo
    [J]. TOXICOLOGY, 2016, 350 : 25 - 30
  • [26] A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods
    Kassa, J
    Cabal, J
    [J]. TOXICOLOGY, 1999, 132 (2-3) : 111 - 118
  • [27] A comparison of the reactivating and therapeutic efficacy of the newly developed bispyridinium oxime K203 with currently available oximes, in sarin poisoned rats and mice
    Kassa, Jiri
    Karasova, Jana Zd'arova
    Sepsova, Vendula
    Bajgar, Jiri
    [J]. JOURNAL OF APPLIED BIOMEDICINE, 2011, 9 (04) : 225 - 230
  • [28] A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats
    Kassa, Jiri
    Karasova, Jana Zdarova
    Musilek, Kamil
    Kuca, Kamil
    Jung, Young-Sik
    [J]. TOXICOLOGY MECHANISMS AND METHODS, 2009, 19 (03): : 232 - 238
  • [29] A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats
    Kassa, Jiri
    Jun, Daniel
    Kuca, Kamil
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (03) : 297 - 300
  • [30] A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats
    Kassa, Jiri
    Jun, Daniel
    Karasova, Jana
    Bajgar, Jiri
    Kuca, Kamil
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 175 (1-3) : 425 - 427
1234